The potential for gene-targeted supplementation of BDNF and other neurotrophic factors to mitigate metabolic burden and compensate for the inadequate transport of trophic factors resulting from axonal damage in human glaucoma warrants further investigation 145, 148. Here, BDNF is linked to glaucoma.